Primary esophageal large T-cell lymphoma mimicking esophageal carcinoma: A case report and literature review  by Wagner, Patrick L. et al.
Brief CommunicationsPrimary esophageal large T-cell lymphoma mimicking esophageal
carcinoma: A case report and literature review
Patrick L. Wagner, MD,a,b Wayne Tam, MD, PhD,b Pauline Y. Lau, MD,c Jeffrey L. Port, MD,a Subroto Paul, MD,a
Nasser K. Altorki, MD,a and Paul C. Lee, MD,a New York, NYSupplemental material is
available online.
W
e report a rare case of primary esophageal T-cell
lymphoma. Although these tumors may be difficult
to distinguish clinically from more common mass
lesions of the esophagus, obtaining an accurate
diagnosis is vital to select an appropriate course of treatment.
Clinical Summary
A 64-year-old Chinese man, with no other significant medical his-
tory, was seen with a 6-month history of dysphagia, initially with
solid food and later progressing to liquids as well. He denied hemop-
tysis, hematemesis, and weight loss and reported an inactive smok-
ing history of 10 pack-years and occasional alcohol consumption.
Results of physical examination were unremarkable, with no palpa-
ble lymphadenopathy, ascites, or organomegaly. Initial laboratory
values, including blood cell counts, were normal.
A barium swallow suggested external compression of the esoph-
agus. On endoscopy, a polypoid necrotic mass was seen just distal to
the upper esophageal sphincter, with associated luminal narrowing
(Figure 1, A). Endoscopic ultrasonography demonstrated a full-
thickness anechoic lesion. Computed tomographic imagery was
notable for thickening of the proximal thoracic esophagus and
subcentimeter mediastinal lymph nodes (Figure E1). Positron emis-
sion tomography revealed marked fluorodeoxyglucose avidity in the
esophageal mass.
Initial attempts at biopsy yielded nondiagnostic material consist-
ing mainly of necrotic debris. Rigid esophagoscopy was used to ob-
tain an adequate biopsy sample, which consisted of an atypical
infiltrate of large lymphocytes (Figure 2, A), demonstrated by immu-
nohistochemical staining to be T cells with loss of CD5 expression.
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of amonoclonal population, and the lesionwas classified as a periph-
eral T-cell lymphoma of the large cell type.
After three cycles of chemotherapy with ifosfamide, methotrex-
ate, etoposide, and prednisone, a 1.4-cm fluorodeoxyglucose-avid
nodule was found in the posterolateral left lung base (Figure 1, B).
Wedge resection was performed, and histologic examination re-
vealed the presence of large, transformed lymphocytes (Figure 2,
B). Flow cytometry distinguished a T-cell population with aberrant
loss of surface CD3 and CD5. A clonal T-cell population related to
the esophageal tumor was demonstrated by gene rearrangement
analysis, consistent with pulmonary involvement by the primary
esophageal lymphoma.
Chemotherapy was administered for six additional cycles with
rituximab, cyclophosphamide, doxorubicin, vincristine, and predni-
sone, after which the patient had no evidence of disease. He under-
went consolidation with high-dose chemotherapy with autologous
stem cell support, a regimen shown to improve survival of patients
with aggressive peripheral T-cell lymphomas.1 He currently remains
without evidence of disease 10 months after the initial diagnosis and
6 months after the lung resection.
Discussion
The esophagus is extremely rare as a primary site of lymphoma.2
Most primary esophageal lymphomas arise in patients older than
50 years,3 and most patients have dysphagia and weight loss, al-
though some have hoarseness and in rare cases esophageal perfora-
tion or tracheoesophageal fistula.4,5 Tumors may arise in the
proximal or distal esophagus, appearing grossly as ulcerated polyp-
oid or circumferential lesions, and may mimic esophageal
carcinoma. In many cases, multiple biopsies have been required to
obtain sufficient tissue for diagnosis.
Most reported primary esophageal lymphomas have been large
cell lymphomas of the B-cell type. Extranodal marginal zone B-
cell lymphomas, Hodgkin lymphomas, and plasma cell neoplasms
have also been reported.2,E1-E4 Only three primary esophageal T-
cell lymphomas have been documented in the literature, 2 of which
were of the large-cell type.2,3 The age range for these other 3 pa-
tients was 17 to 34 years, whereas our patient was in his seventh
decade. The previous cases involved the lower esophagus, in con-
trast to the upper esophageal location in our case. Survival of these
previously reported patients ranged from 6 to 14 months after
diagnosis. No standard optimal treatment regimen exists for esoph-
ageal lymphomas, although radiation and chemotherapy with
regimens including cyclophosphamide, doxorubicin, vincristine,
and prednisone have been used. Presumably, the prognosis
depends on the stage and subtype of lymphoma and its response
to treatment.
In this case, the appearance of a lung lesion after initial
chemotherapy for lymphoma limited the differential diagnosis toracic and Cardiovascular Surgery c Volume 135, Number 4 957
Brief CommunicationsFigure 2. A, Esophageal involvement by T-cell
lymphoma; overlying squamous mucosa is appar-
ent in upper half of image. B, Interstitial pulmonary
infiltrate composed of malignant T-cells; note pre-
served alveolar architecture on upper left of field.
Figure 1. A, Endoscopic photograph of mass le-
sion (arrow) and adjacent area of ulceration (ar-
row, inset). B, Positron emission tomographic
scan with fluorodeoxyglucose-avid lesions in
esophagus and left lower lung field (arrows).pulmonary involvement by lymphoma, an infectious complication of
treatment, or primary lung carcinoma. Had the lung lesion been syn-
chronous with a constricting esophageal mass, an esophageal carci-
noma with pulmonary metastases would have been favored in the
differential diagnosis. This case underscores the importance of a me-
thodical diagnostic workup, because the therapeutic options differ
drastically among the entities in the differential diagnosis.
In summary, the esophagus is a rare primary site of lymphoma.
Primary esophageal lymphomas may mimic carcinoma clinically
and in gross appearance, and it is characteristically difficult to obtain
sufficient tissue for diagnosis in the initial biopsies of these lesions.
In clinical settings suggestive of lymphoma, intraoperative patho-
logic examination of a biopsy sample should be undertaken to
ensure that sufficient material is obtained for histologic, immuno-
phenotypic, and molecular analyses for accurate classification of
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Figure E1. A, Computed tomographic scan with
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arch. B, Computed tomographic scan shows pe-
ripheral lung nodule in posterior left lower lobe
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